Human prostate cancer: a direct role for oestrogens

Area of Science:

• Endocrinology
• Oncology
• Molecular Biology

Background:

• Prostate cancer hormone-dependence is typically modeled via androgens.
• Oestrogen's role in prostate cancer remains incompletely understood.
• Recent data highlight prostate cancer's increasing prevalence and mortality.

Purpose of the Study:

• To investigate oestrogen's effect on responsive (LNCaP) and non-responsive (PC3) human prostate cancer cell lines.
• To elucidate the mechanisms underlying oestrogen's differential effects on these cell lines.
• To reassess the current model of hormone-dependence in human prostatic carcinoma.

Main Methods:

• Radioligand binding assays to detect oestrogen binding.
• Immunocytochemistry for oestrogen and progesterone receptors.
• Reverse transcriptase polymerase chain reaction (RT-PCR) for oestrogen receptor mRNAs.
• Immunofluorescence for heat shock protein 27 (Hsp27) as a marker of functional oestrogen receptors.
• Cell proliferation assays with and without oestrogen and specific inhibitors/antibodies.

Main Results:

• Oestradiol significantly stimulated LNCaP cell growth, comparable to androgens.
• Oestradiol significantly inhibited PC3 cell proliferation.
• Functional oestrogen receptors were confirmed in LNCaP cells.
• Lower oestrogen receptor expression was observed in PC3 cells compared to LNCaP cells.
• Oestradiol's effect on LNCaP cells was mediated via its receptor, reversed by ICI 182,780.
• Oestradiol-induced inhibition in PC3 cells may involve transforming growth factor-beta 1 (TGF-beta 1).

Conclusions:

• Oestrogen exerts differential effects on human prostate cancer cell lines.
• The findings challenge the traditional androgen-centric model of prostate cancer hormone-dependence.
• A revised model incorporating oestrogen's complex role is warranted, given prostate cancer's significant public health impact.